ArticleCureus2025
Selective Feticide in a Dichorionic Twin Pregnancy After IVF Following Diagnosis of Trisomy 21 in One Twin: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In multiple pregnancies complicated by a severe fetal anomaly, selective feticide may be performed to reduce maternal risks and improve the prognosis of the unaffected twin. We present the case of a 38-year-old patient who conceived through in vitro fertilization (IVF) and was diagnosed with a dichorionic diamniotic twin pregnancy discordant for trisomy 21. Non-invasive prenatal testing (NIPT) indicated a high risk for trisomy 21 in the second twin, which was subsequently confirmed by amniocentesis and molecular genetic testing. The first twin demonstrated a normal male karyotype, whereas the second twin exhibited a male karyotype with trisomy 21. Given that selective feticide is not legally allowed in Bosnia and Herzegovina, the patient was referred to the Clinical Center of Serbia in Belgrade. Following ethical approval, selective feticide of the affected twin was performed at 33+1 weeks of gestation. The cesarean delivery at 33+6 weeks resulted in one live male neonate (2,440 g, Apgar score 6) and one stillborn male (1,900 g, Apgar score 0). The maternal postoperative course was uneventful, and the surviving infant demonstrated normal growth and neurodevelopment at one-month follow-up. This case underscores the importance of early genetic screening, multidisciplinary counseling, and awareness of legal and ethical frameworks that may necessitate cross-border management in twin pregnancies discordant for chromosomal abnormalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.